AIFM2 and cancer: Bersuker et al. recently found that when GPX4 was inactivated, FSP1 could maintain the growth of lung cancer cells, which implied that FSP1 contributed to the resistance against cell ferroptosis and might be one important drug target for cancer treatment (Bersuker et al., 2019).